Schrödinger 24th European User Group Meeting
May 19–21, 2026, Munich, Germany
Coriolis Pharma will take part in the 24th Schrödinger European User Group Meeting, a conference centered on computational approaches in pharmaceutical research. The event brings together scientists and industry professionals to discuss how molecular modeling and simulation support drug discovery and development.
Dr. Maximilian Allgöwer, Scientist at Coriolis Pharma, will contribute to the scientific program with a presentation titled:
“Accelerating and de-risking developability assessment and formulation development of monoclonal antibodies and other proteins using in silico methods.”
Our team will be in Munich throughout the meeting to exchange ideas with researchers and partners working at the interface of modeling, analytics, and drug product development.
